Our Intellectual Property

---

At Firstlight Pharmaceuticals, our patent portfolio focuses on innovative drug delivery that enhances cellular targeting in order to develop therapies that are both efficacious and well-tolerated. This dual focus ensures that our approach optimizes therapeutic impact while minimizing potential side effects, offering a comprehensive solution for addressing unmet medical needs. Our proprietary approach focuses on leveraging biological transporters to enhance drug uptake at specific tissue sites. This innovative approach enables more precise delivery, potentially improving efficacy and reducing side effects. Our patented technologies include methods for modulating G-protein coupled receptors (GPCRs), which play a key role in many physiological processes. By influencing GPCR activity, we aim to create therapies that offer better therapeutic outcomes. 

We are actively expanding our patent portfolio to cover additional therapeutic areas. Our research continues to explore new applications for our technology, including potential treatments for oncology and metabolic disorders.